Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11158)	11/15/1997 2:10:00 PM
From: JOEBT1	Read Replies (6) \| Respond to of 32384

Henry, you have been and continue to be a tremendous asset to all serious investors on this thread. Please continue your science/business relevant posts to this thread with your usual energy and frequency. I have adhered to a rule of posting only relevant science/business comments that may result in increased knowledge of LGND's prospects. ( I must say I'm somewhat disappointed that they have stimulated no response while social and non-substantial negative comments generate a torrent of posts--all useless to our common purpose of making money on LGND.) Back to business--do you know the status of the LGND's lawsuit against Pfizer on non-payment of Droloxifene milestone payments? Does LGND really have royalty rights that Pfizer recognizes? What is status of psoriasis trial? I've got a call in to Atkins on these questions and others---but would appreciate any info from you and others.